Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    How Chinese carmaker Geely put roots in the U.S.

    May 4, 2026

    Swiss lawmakers delay UBS capital rules decision until August

    May 4, 2026

    Circle jumps 20% on Clarity Act compromise that preserves stablecoin rewards

    May 4, 2026
    Facebook X (Twitter) Instagram
    Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets
    Home»Politics»Supreme Court lifts mail ban on abortion pill mifepristone
    Politics

    Supreme Court lifts mail ban on abortion pill mifepristone

    franperez66q@protonmail.comBy franperez66q@protonmail.comMay 4, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email


    In this photo illustration, A packet of Mifepristone is seen at Wyoming’s last abortion clinic, Wellspring Center March 10, 2025 in Casper, Wyoming.

    Natalie Behring | Getty Images

    The U.S. Supreme Court on Monday temporarily lifted a lower court’s ban on the abortion pill mifepristone being sent through the mail.

    The administrative stay of the ban on mailing of mifepristone issued Friday by the 5th U.S. Circuit Court of Appeals will continue until at least 5 p.m. ET May 11, but could be extended after that.

    Supreme Court Justice Samuel Alito, who granted the temporary pause, gave the state of Louisiana until 5 p.m. Thursday to respond to requests that the 5th Circuit’s ruling be blocked as litigation over the issue plays out.

    Read more CNBC politics coverage

    Two drugmakers, Danco Laboratories and GenBioPro, over the weekend asked the Supreme Court to lift the ban on mifepristone being distributed through the mail.

    The drug is used in about two-thirds of all abortions in the United States.

    Louisiana had sued the Food and Drug Administration over its 2023 decision to lift a rule that mifepristone had to be administered in person.

    Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    Judge blasts Cole Allen treatment by jail in Trump case

    May 4, 2026

    UAE says it intercepted Iranian missiles for first time since ceasefire began

    May 4, 2026

    U.S. military denies Iran’s claim it struck warship in Strait of Hormuz

    May 4, 2026

    Reform pledges to open migrant detention centres in Green-voting areas

    May 4, 2026

    Warsh’s take on Fed independence is met with confusion, concern

    May 4, 2026

    Chris Mason: Elections this week a smorgasbord of competitiveness

    May 4, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    How Chinese carmaker Geely put roots in the U.S.

    May 4, 2026

    Swiss lawmakers delay UBS capital rules decision until August

    May 4, 2026

    Circle jumps 20% on Clarity Act compromise that preserves stablecoin rewards

    May 4, 2026

    Judge blasts Cole Allen treatment by jail in Trump case

    May 4, 2026
    © 2026 All right reserved
    • About Us
    • Privacy Policy
    • Terms & Conditions
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.